Instil Bio (TIL) Interest Expenses (2022 - 2026)
Instil Bio (TIL) posted Interest Expenses of $1.6 million for Q2 2026, up 1.93% on a QoQ basis from $1.6 million in Q1 2026, and little changed year-over-year from $1.6 million in Q2 2025.
Analysis
Instil Bio (TIL) Interest Expenses (2022 - 2026) Analysis & Trends
Instil Bio has reported Interest Expenses for 5 years, with the latest figure at $1.6 million in Q2 2026.
- On a quarterly basis, Interest Expenses changed 0.0% year-over-year to $1.6 million in Q2 2026; TTM through Jun 2026 was $6.3 million, a 18.31% decrease from a year earlier, with the FY2025 full-year figure at $5.8 million, down 35.18% from the prior year.
- Interest Expenses was $1.6 million for Q2 2026 at Instil Bio, up from $1.6 million in the prior quarter.
- The five-year high for Interest Expenses was $3.0 million in Q4 2024, with the low at $331000.0 in Q2 2022.
- Average Interest Expenses over 5 years is $1.5 million, with a median of $1.6 million recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses soared 238.81% in 2024, then plunged 47.84% in 2025.
- Over 5 years, Interest Expenses stood at $745000.0 in 2022, then surged by 165.77% to $2.0 million in 2023, then jumped by 51.72% to $3.0 million in 2024, then slumped by 47.84% to $1.6 million in 2025, then grew by 0.96% to $1.6 million in 2026.
- The last three Interest Expenses figures came in at $1.6 million (Q2 2026), $1.6 million (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 673.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 247.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 11.00 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -1.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Instil Bio | 50.19 Mn | 50.19 Mn | - | 1.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.58 Mn |
| Mar 31, 2026 | 1.55 Mn |
| Dec 31, 2025 | 1.57 Mn |
| Sep 30, 2025 | 1.58 Mn |
| Jun 30, 2025 | 1.58 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | 1.98 Mn |
| Dec 31, 2023 | 1.98 Mn |
| Sep 30, 2023 | 2.00 Mn |
| Jun 30, 2023 | 590,000.00 |
| Mar 31, 2023 | 636,000.00 |
| Dec 31, 2022 | 745,000.00 |
| Sep 30, 2022 | 807,000.00 |
| Jun 30, 2022 | 331,000.00 |